Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
JHEP Reports : Innovation in Hepatology|June 17, 2025
Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosisJim Benjamin Mauz, Lukas Hartl, Andrea Kornfehl, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2026
Stage-specific drivers of clinical progression in advanced chronic liver diseaseBenedikt Simbrunner, Georg Semmler, Marta Bofill Roig, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 7, 2025
UDFF and Auto pSWE accurately assess liver steatosis and fibrosis risk in obese patients with MASLDNina Dominik, Larissa Nixdorf, Michael Schwarz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2026
Post-TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS PlacementMarlene Hintersteininger, Simon Johannes Gairing, Katrin Kirsch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 4, 2025
The Vasopressin Biomarker Copeptin is Linked to Systemic Inflammation and Refines Prognostication in Decompensated CirrhosisLukas Hartl, Marlene Hintersteininger, Benedikt Simbrunner, et al.
Hepatology (Baltimore, Md.)|March 6, 2024
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertensionGeorg Semmler, Lukas Hartl, Yuly Paulin Mendoza, et al.
Hepatology (Baltimore, Md.)|May 21, 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver diseaseLukas Hartl, Katharina Haslinger, Martin Angerer, et al.
JHEP Reports : Innovation in Hepatology|January 19, 2026
Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver diseaseGeorg Kramer, Benedikt Simbrunner, Mathias Jachs, et al.
JHEP Reports : Innovation in Hepatology|March 28, 2026
Response-guided bulevirtide ± pegylated interferon alfa-2a: long-term outcomes observed in the nationwide Austrian hepatitis D cohort studyMichael Schwarz, Marlene Hintersteininger, Caroline Schwarz, et al.
Hepatology (Baltimore, Md.)|January 8, 2025
Identification of optimal portal pressure decrease to control ascites while minimizing HE after TIPS: A multicenter studyMartin A Kabelitz, Lukas Hartl, Golda Schaub, et al.
Pageof 18